FEB 17, 2019 3:17 PM PST

Drug Combination May Become Standard Treatment for Metastatic Kidney Cancer

WRITTEN BY: Nouran Amin

Reporting from results of a phase 3 clinical trial, patients with metastatic kidney cancer may soon receive a new standard treatment involving a combination of two drugs. The drugs, axitinib plus the immunotherapeutic agent avelumab, were seen to significantly decrease tumor size better that the current treatment involving the drug sunitinib (Sutent), used specifically in the treatment of renal cell carcinoma.

Learn more about kidney cancers:

"Patients receiving the drug combination also had a higher response rate -- meaning their tumors shrank -- than the sunitinib-only group," says Toni K. Choueiri, MD, senior and co-corresponding author of the report and The Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School. "This is certainly better than sunitinib -- hopefully this will lead to Food and Drug Administration approval soon.”

The drug combination, particularly involving the immunotherapeutic—avelumab, works by not only targeting the vascular endothelial growth factor receptor (VEGFR) to disrupt the blood supply to tumors but by also inhibiting and immune checkpoint called PD-L1 which naturally works to exhausts immune T cells—this will ensure the effective attack of cancer cells.

"Interestingly, the analysis showed that all subgroups -- good, intermediate, and poor-risk patient -- benefited from the combination treatment," said Choueiri. This was the topic of an oral presentation Choueiri has just given at the 2019 Genitourinary Cancers Symposium in San Francisco. The results were simultaneously published in the New England Journal of Medicine.

Almost all patients in the study experienced some form of side effects—with the most frequent being thyroid disorders in the drug combination group. However, Dr. Choueiri states that for patients with advanced stage of cancer, the drug combination will serve as "an important option. What we're doing in advanced kidney cancers is pushing the envelope -- these treatments may not be curative, but patients are living longer, and the disease is becoming more chronic."

Source: Dana-Farber Cancer Institute

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Using Vitamins to Treat Pediatric Sepsis
New research indicates that is very much possible to treat pediatric septic shock in children with a combination of intravenous vitamin C and intravenous v...
FEB 27, 2020
Drug Discovery & Development
FEB 27, 2020
New Drug Shows Promise in Treating Chronic Cough
Between 4% and 10% of adults around the world have an unexplainable chronic cough that has lasted for over 8 weeks. Although no treatments are currently av...
MAR 07, 2020
Drug Discovery & Development
MAR 07, 2020
Single Trip on Magic Mushrooms Boosts Mindfulness
According to new research, a single trip from magic mushrooms is enough for people to experience long-term increases in mindfulness and openness. Mindfulne...
MAR 06, 2020
Drug Discovery & Development
MAR 06, 2020
Drug Improves Cancer Therapy
Prochlorperazine (PCZ) is a drug used for psychiatric use and the therapeutic treatment of nausea but was recently found to block the internalization of mo...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Is Fast-Tracking Vaccines for Coronavirus Really Such a Good Idea?
Donald Trump has called on researchers to “slash red tape like nobody has even done it before” to accelerate the development of vaccines for th...
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Treatments Used For Cattle Affect Wildlife
Common drug treatments used in cattle, such as de-worming and anti-ectoparasitic products, have held effect on wildlife which urged researchers to find imm...
Loading Comments...